Search
for
Sort by
Research 31–60 of 396
- Sildenafil: Looking Beyond Erectile Dysfunction: A Dermatological Perspective
- Description of skin lesions
- Off-Label Use of Botulinum Toxin in Dermatology—Current State of the Art
- Pediatric Sjögren’s Syndrome: Focus on Ocular Involvement and Diagnostic Challenges
- Protein-losing Enteropathy Exacerbated with the Appearance of Symptoms of Systemic Lupus Erythematosus.
- Nifedipine: a new treatment for perniosis
- Botulinum Toxins in Medical and Cosmetic Dermatology
- The effect of changes in temperature on peripheral blood flow in systemic sclerosis
- [Successful treatment of "steroid-immunosuppressant resistant" polymyositis with immunoadsorption].
- Response of Hemiballismus to Haloperidol-Reply
- Adverse Reactions to Enemas
- Letters: CD4+ Lymphocytopenia in Systemic Lupus Erythematosus
- E031 Retinal vasculitis with Libman-Sacks endocarditis as presenting features of a systemic lupus erythematosus with antiphospholipid antibody syndrome patient
- Subacute cutaneous lupus erythematosus presenting as erythroderma
- Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
- Essential Thrombocythemia: The Dermatologic Point of View
- CUTANEOUS SIDE-EFFECTS OF BETA-ADRENERGIC BLOCKERS
- Cutaneous manifestations of systemic lupus erythematosus in Pakistani children
- Clinical Patterns of Cutaneous and Mucosal Lesions in Patients with Systemic Lupus Erythematosus
- SP0227 Case 1 Presentation: Arthritis, Lupus and More. Rhupus or Polyautoimmunity?
- October 27, 1978
- Wording Creates Misunderstanding
- Cutaneous complications of chemotherapeutic agents
- THE FREQUENCY OF VISCERAL AND PHENOTYPIC MARKERS IN PATIENTS WITH THE COMBINATION OF UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE AND GASTROESOPHAGEAL REFLUX DISEASE
- Immunologic adverse reactions of β-blockers and the skin (Review)
- Nitroglycerin in Dermatology
- Coexistence of acquired localized hypertrichosis and lipoatrophy after lupus panniculitis
- Preclinical Pharmacology, Antitumor Activity, and Development of Pharmacodynamic Markers for the Novel, Potent AKT Inhibitor CCT128930
- Cytostatics and immunosuppressive drugs
- Approach to Patients with Suspected Rheumatic Disease